I don't have a problem with drug companies paying academic doctors, other healthcare professionals or researchers for work/advice/consultancy, provided that all payments are fully publically declared.
It is not unusual for a speaker to thank a drug company before a seminar in healthcare circles, the audience understands what this means and are usually more challenging.
Mark Walker - Oxfordshire, England. Registered Pharmacist (UK). 11 years of study around MS.
Mark's CCSVI Report 7-Mar-11: